CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma

DSpace/Manakin Repository

CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma

Citable link to this page

 

 
Title: CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma
Author: Gao, Yan; Feng, Yong; Shen, Jacson K.; Lin, Min; Choy, Edwin; Cote, Gregory M.; Harmon, David C.; Mankin, Henry J.; Hornicek, Francis J.; Duan, Zhenfeng

Note: Order does not necessarily reflect citation order of authors.

Citation: Gao, Yan, Yong Feng, Jacson K. Shen, Min Lin, Edwin Choy, Gregory M. Cote, David C. Harmon, Henry J. Mankin, Francis J. Hornicek, and Zhenfeng Duan. 2015. “CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.” Scientific Reports 5 (1): 11365. doi:10.1038/srep11365. http://dx.doi.org/10.1038/srep11365.
Full Text & Related Files:
Abstract: Osteosarcoma is the most common primary bone malignancy in children and adolescents. Herein, we investigated the role of cluster of differentiation 44 (CD44), a cell-surface glycoprotein involved in cell-cell interactions, cell adhesion, and migration in osteosarcoma. We constructed a human osteosarcoma tissue microarray with 114 patient tumor specimens, including tumor tissues from primary, metastatic, and recurrent stages, and determined the expression of CD44 by immunohistochemistry. Results showed that CD44 was overexpressed in metastatic and recurrent osteosarcoma as compared with primary tumors. Higher expression of CD44 was found in both patients with shorter survival and patients who exhibited unfavorable response to chemotherapy before surgical resection. Additionally, the 3′-untranslated region of CD44 mRNA was the direct target of microRNA-199a-3p (miR-199a-3p). Overexpression of miR-199a-3p significantly inhibited CD44 expression in osteosarcoma cells. miR-199a-3p is one of the most dramatically decreased miRs in osteosarcoma cells and tumor tissues as compared with normal osteoblast cells. Transfection of miR-199a-3p significantly increased the drug sensitivity through down-regulation of CD44 in osteosarcoma cells. Taken together, these results suggest that the CD44-miR-199a-3p axis plays an important role in the development of metastasis, recurrence, and drug resistance of osteosarcoma. Developing strategies to target CD44 may improve the clinical outcome of osteosarcoma.
Published Version: doi:10.1038/srep11365
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468826/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:17295765
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters